Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

ATAD5 deficiency alters DNA damage metabolism and sensitizes cells to PARP inhibition

S. Giovannini, MC. Weller, H. Hanzlíková, T. Shiota, S. Takeda, J. Jiricny,

. 2020 ; 48 (9) : 4928-4939. [pub] 20200521

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025002

Replication factor C (RFC), a heteropentamer of RFC1-5, loads PCNA onto DNA during replication and repair. Once DNA synthesis has ceased, PCNA must be unloaded. Recent findings assign the uloader role primarily to an RFC-like (RLC) complex, in which the largest RFC subunit, RFC1, has been replaced with ATAD5 (ELG1 in Saccharomyces cerevisiae). ATAD5-RLC appears to be indispensable, given that Atad5 knock-out leads to embryonic lethality. In order to learn how the retention of PCNA on DNA might interfere with normal DNA metabolism, we studied the response of ATAD5-depleted cells to several genotoxic agents. We show that ATAD5 deficiency leads to hypersensitivity to methyl methanesulphonate (MMS), camptothecin (CPT) and mitomycin C (MMC), agents that hinder the progression of replication forks. We further show that ATAD5-depleted cells are sensitive to poly(ADP)ribose polymerase (PARP) inhibitors and that the processing of spontaneous oxidative DNA damage contributes towards this sensitivity. We posit that PCNA molecules trapped on DNA interfere with the correct metabolism of arrested replication forks, phenotype reminiscent of defective homologous recombination (HR). As Atad5 heterozygous mice are cancer-prone and as ATAD5 mutations have been identified in breast and endometrial cancers, our finding may open a path towards the therapy of these tumours.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025002
003      
CZ-PrNML
005      
20201222153635.0
007      
ta
008      
201125s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/nar/gkaa255 $2 doi
035    __
$a (PubMed)32297953
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Giovannini, Sara $u Institute of Molecular Life Sciences of the University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland. Institute of Molecular Cancer Research of the University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland. Institute of Biochemistry of the Swiss Federal Institute of Technology, Otto-Stern-Weg 3, 8093 Zurich, Switzerland.
245    10
$a ATAD5 deficiency alters DNA damage metabolism and sensitizes cells to PARP inhibition / $c S. Giovannini, MC. Weller, H. Hanzlíková, T. Shiota, S. Takeda, J. Jiricny,
520    9_
$a Replication factor C (RFC), a heteropentamer of RFC1-5, loads PCNA onto DNA during replication and repair. Once DNA synthesis has ceased, PCNA must be unloaded. Recent findings assign the uloader role primarily to an RFC-like (RLC) complex, in which the largest RFC subunit, RFC1, has been replaced with ATAD5 (ELG1 in Saccharomyces cerevisiae). ATAD5-RLC appears to be indispensable, given that Atad5 knock-out leads to embryonic lethality. In order to learn how the retention of PCNA on DNA might interfere with normal DNA metabolism, we studied the response of ATAD5-depleted cells to several genotoxic agents. We show that ATAD5 deficiency leads to hypersensitivity to methyl methanesulphonate (MMS), camptothecin (CPT) and mitomycin C (MMC), agents that hinder the progression of replication forks. We further show that ATAD5-depleted cells are sensitive to poly(ADP)ribose polymerase (PARP) inhibitors and that the processing of spontaneous oxidative DNA damage contributes towards this sensitivity. We posit that PCNA molecules trapped on DNA interfere with the correct metabolism of arrested replication forks, phenotype reminiscent of defective homologous recombination (HR). As Atad5 heterozygous mice are cancer-prone and as ATAD5 mutations have been identified in breast and endometrial cancers, our finding may open a path towards the therapy of these tumours.
650    _2
$a ATPázy spojené s různými buněčnými aktivitami $x genetika $x metabolismus $7 D000074183
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x farmakologie $7 D000970
650    _2
$a buněčné linie $7 D002460
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a kur domácí $7 D002645
650    _2
$a chromatin $x enzymologie $7 D002843
650    _2
$a DNA $x metabolismus $7 D004247
650    12
$a poškození DNA $7 D004249
650    _2
$a DNA vazebné proteiny $x genetika $x metabolismus $7 D004268
650    _2
$a nestabilita genomu $7 D042822
650    _2
$a mutageny $x toxicita $7 D009153
650    _2
$a ftalaziny $x farmakologie $7 D010793
650    _2
$a piperaziny $x farmakologie $7 D010879
650    _2
$a poly(ADP-ribosa)polymerasa 1 $x metabolismus $7 D000071137
650    _2
$a PARP inhibitory $x farmakologie $7 D000067856
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Weller, Marie-Christine $u Institute of Molecular Cancer Research of the University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
700    1_
$a Hanzlíková, Hana $u Department of Genome Dynamics, Institute of Molecular Genetics of the Czech Academy of Sciences, 142-20 Prague 4, Czech Republic. Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9RQ, UK.
700    1_
$a Shiota, Tetsuya $u Department of Radiation Genetics, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan.
700    1_
$a Takeda, Shunichi $u Department of Radiation Genetics, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan.
700    1_
$a Jiricny, Josef $u Institute of Molecular Life Sciences of the University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland. Institute of Molecular Cancer Research of the University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland. Institute of Biochemistry of the Swiss Federal Institute of Technology, Otto-Stern-Weg 3, 8093 Zurich, Switzerland.
773    0_
$w MED00003554 $t Nucleic acids research $x 1362-4962 $g Roč. 48, č. 9 (2020), s. 4928-4939
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32297953 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222153631 $b ABA008
999    __
$a ok $b bmc $g 1599147 $s 1115688
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 48 $c 9 $d 4928-4939 $e 20200521 $i 1362-4962 $m Nucleic acids research $n Nucleic Acids Res $x MED00003554
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace